Organizational Practices
As AI becomes increasingly integrated into healthcare decision-making, understanding payer expectations is critical.
This poster explores US payer perspectives on drug manufacturer readiness for AI, finding that while payers are receptive to AI-supported evidence and analytics, trust depends on transparency, governance, validation, and data quality. The findings highlight that successful AI adoption will require not only innovation, but also the credibility and safeguards needed to support confident decision-making.
Download full case study
